Radboud University Medical Center, The Netherlands.
Canisius Wilhelmina Hospital, The Netherlands.
Health Informatics J. 2020 Jun;26(2):1194-1207. doi: 10.1177/1460458219873528. Epub 2019 Sep 30.
For the treatment choice of localized prostate cancer, effective patient decision aids have been developed. The implementation of decision aids in routine care, however, lags behind. Main known barriers are lack of confidence in the tool, lack of training on its use, lack of resources and lack of time. A new implementation strategy addresses these barriers. Using this implementation strategy, the implementation rate of a decision aid was measured in eight hospitals and questionnaires were filled out by 24 care providers and 255 patients. The average implementation rate was 60 per cent (range 31%-100%). Hardly any barriers remained for care providers. Patients who did not use the decision aid appeared to be more unwilling than unable to use the decision aid. By addressing known barriers, that is, informing care providers on the effectiveness of the decision aid, providing instructions on its use, embedding it in the existing workflow and making it available free of charge, a successful implementation of a prostate cancer decision aid was reached.
对于局限性前列腺癌的治疗选择，已经开发出有效的患者决策辅助工具。然而，这些决策辅助工具在常规护理中的实施却滞后不前。主要的已知障碍包括对工具缺乏信心、缺乏使用工具的培训、缺乏资源和缺乏时间。一种新的实施策略解决了这些障碍。使用这种实施策略，在八家医院测量了一种决策辅助工具的实施率，并由 24 名护理提供者和 255 名患者填写了调查问卷。实施率平均为 60%（范围为 31%-100%）。对于护理提供者来说，几乎没有任何障碍。没有使用决策辅助工具的患者似乎是不愿意使用，而不是不能使用该决策辅助工具。通过解决已知的障碍，即向护理提供者告知决策辅助工具的有效性、提供使用说明、将其嵌入现有工作流程并免费提供，成功地实施了前列腺癌决策辅助工具。
